Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Asthma | R-HSA-444620 | map05310 | pentoxifylline | 4740 | drug-path |
GnRH signaling pathway | R-HSA-168638 | map04912 | pentoxifylline | 4740 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | pentoxifylline | 4740 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | pentoxifylline | 4740 | drug-path |
RNA polymerase | R-HSA-73864 | map03020 | pentoxifylline | 4740 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | meclofenamic acid | 4037 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | meclofenamic acid | 4037 | drug-path |
Homologous recombination | R-HSA-5685942 | map03440 | meclofenamic acid | 4037 | drug-path |
Alzheimer's disease | R-HSA-1643685 | 0 | tiapride | 5467 | drug-path |
Neuroactive ligand-receptor interaction | R-HSA-5632681 | map04080 | tiapride | 5467 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | tiapride | 5467 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | tiapride | 5467 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | tinidazole | 4037 | drug-path |
T cell receptor signaling pathway | R-HSA-983705 | map04660 | tinidazole | 4037 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | tinidazole | 4037 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | tinidazole | 4037 | drug-path |
VEGF signaling pathway | R-HSA-194138 | map04370 | tinidazole | 4037 | drug-path |
Allograft rejection | R-HSA-9679028 | map05330 | tinidazole | 4037 | drug-path |
Long-term depression | R-HSA-9620244 | map04730 | tinidazole | 4037 | drug-path |
Type I diabetes mellitus | R-HSA-5683209 | map04940 | tinidazole | 4037 | drug-path |